A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
about
Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage displayEffect of FGF-binding protein 3 on vascular permeabilityPhysiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrinBeyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesisFibroblast growth factor-binding protein is a novel partner for perlecan protein corePleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growthThe fibroblast growth factor binding protein is a novel interaction partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity: implications for epithelial repairTissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the ratA distinct role for secreted fibroblast growth factor-binding proteins in development.Structural characterization of the fibroblast growth factor-binding protein purified from bovine prepartum mammary gland secretion.Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.Anti-vascular therapy: a new approach to cancer treatment.Expression of fibroblast growth factor binding protein in head and neck cancer.Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.Fibroblast growth factor-binding protein expression changes with disease progression in clinical and experimental human squamous epithelium.Angiogenesis in head and neck squamous cell carcinoma.Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein.Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arenaThe Fibroblast Growth Factor signaling pathwayExpression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Fibroblast growth factors in cancer: therapeutic possibilities.Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing.Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.A novel enhancer of the wound healing process: the fibroblast growth factor-binding protein.Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing.Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growthThe angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcomeMatrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelAnti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric studyThe basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing.Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
P2860
Q24293106-0019BDD6-6C1C-49B0-BDAE-CBE5FBB6CEFEQ24318815-A505FF5D-AFC5-4A6E-9CA0-E20F9102753BQ24641850-1C1B6AE4-F637-4B39-8325-55C0A85B8102Q27026936-97F30F28-44D7-476B-935E-94D4CFB1C27FQ28142123-4B17853A-C78B-4E42-87A6-F87510BDE6E8Q28216536-8E3CE70C-6CFF-4C92-88BA-844167579413Q28243190-B240813E-EF26-4A17-8BFE-C9023E38177AQ28566990-D9CACB6B-E06D-4643-A664-C646500A96DCQ30487901-297B040F-2338-406A-9613-431AB953ACADQ30882422-E1F6B8EC-44F8-4764-8946-30826E10D535Q33369576-3029B3B2-73A7-4134-8F01-9970A9D8B6D8Q33545016-EF37BEAA-EFEC-4FFA-A061-1F9807581C11Q33727133-65317FDC-E76A-49A9-8AE6-862F586FAB1AQ33754972-7CB3BEDE-9ECA-43E4-87A4-CF943BCEC5E2Q33897293-58F576A8-9911-4CCF-901B-AEAA89D2C4DDQ33941650-DFDF15B7-86B8-4E7D-B14A-4694F5106ADBQ34004670-E587D0EC-6990-48F5-A027-A7296463E401Q34027580-4BBFD38B-CF1D-417F-8C18-F84C4868346BQ34087175-98A0461B-7B8E-4B46-B4CF-E826BA56D0E3Q34328750-6DFBD471-A64B-4908-9BC0-9097B2B0A40CQ34467171-0A5D33AF-7024-4DFA-A365-ABB029C32260Q34561928-AFB7D174-A67F-41E8-98A4-E8ADEB71E3F1Q34602545-7E6C215A-D65C-4F01-8618-4BB1F948B232Q34837255-EA8970DA-0397-479F-8F83-28E19DB50497Q34928509-B1CCAF33-3718-48DA-A17E-0D42FA5E6F83Q35067591-409D5CD6-3646-4019-A5DD-712A047BD7A8Q35352420-4ABE57B0-70EE-426A-8052-C9AE0BD39CF2Q35474131-86C318B4-90CB-4FCD-8CCD-B722AE9AB60EQ35474182-2DFF2A8B-01B8-4CEA-9471-55A7E47C3710Q35589581-1B17EB71-14E5-4F26-AF7C-6ABB9D3D726BQ35608989-0C60417C-7B8E-4FAB-8665-B2FC2B55E9D3Q35623040-8DB89726-30E7-4873-A79E-844CD1BE8913Q35665035-2150FE36-A980-42FA-A7C1-649FB3175162Q35763501-0E7A66F1-070F-4C71-8AC2-C5C542FCCA08Q35765199-D04129EB-FAC7-45DB-842F-AF94365A0943Q35765422-929FD888-0FD3-4253-B1A1-CD313E2019DEQ35791487-056F4403-4C18-4CB6-AE13-2F132B957985Q35810000-AD310B3C-AC12-46D3-BF97-A9A230250F1AQ35952104-C46FAFAF-E8D9-442D-9D65-1D711D5D3CAFQ36631534-43D765AF-299F-47EE-9D80-A3986F2F57C6
P2860
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@ast
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@en
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@nl
type
label
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@ast
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@en
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@nl
prefLabel
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@ast
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@en
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
@nl
P2093
P2860
P356
P1433
P1476
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
@en
P2093
A T Tuveson
E D Liaudet-Coopman
F Czubayko
P2860
P2888
P304
P356
10.1038/NM1097-1137
P407
P577
1997-10-01T00:00:00Z